Back to Pictet Asset Management Holding SA Pictet Asset Management Holding SA

DNLIDNLI
Showing 8 of 12 quarters

Position history for Pictet Asset Management Holding SAPictet Asset Management Holding SA's holdings in DENALI THERAPEUTICS INC

Pictet Asset Management Holding SA holds 2.8M shares of DNLI (DENALI THERAPEUTICS INC), worth $71.9M as of 2026-Q2. The position was increased (+9.1% shares). DNLI represents 0.1% of Pictet Asset Management Holding SA's portfolio.

Current Value

$71.9M

Current Shares

2.8M

Total Value Change

+$71.4M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+9.1%
$71.9M0.1%$25.72
32
2026-Q1
Increased
2.6M
+92.5%
$48.4M0.1%$20.02
46
2025-Q4
Increased
1.3M
+166.3%
$22M0.0%$16.41
46
2025-Q3
Increased
499,162
+20.3%
$7.2M0.0%$14.52
33
2025-Q2
Increased
415,112
+20.7%
$5.9M0.0%$14.10
32
2025-Q1
Increased
343,959
+1677.0%
$5.1M0.0%$14.78
43
2024-Q4
Increased
19,356
+16.9%
$394,4750.0%$20.24
28
2024-Q3
Increased
16,550
+20.0%
$482,1010.0%$29.43
29

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used